ulants administered for a duration guided by the patientâ€™s
underlying risk factors. Evidence-based guidelines for the
anticoagulant treatment of acute DVT are regularly updated by the ACCP.24 With anticoagulation, cumulative
rates of freedom from recurrent DVT after thrombolytic
treatment have been reported to be 85%, 83%, and 83% at
6, 12, and 24 months.69 Although